再鼎医药（纳斯达克代码：ZLAB）报告季度损失为每股$(0.80)，这比去年同期每股$(0.98)的损失增加了18.37%。公司报告季度销售额为$109.07百万，超出分析师一致预期的$108.17百万，超出0.83%。这比去年同期的$65.83百万的销售额增加了65.68%。

以上内容来自Benzinga Earnings专栏，原文如下：

Zai Lab (NASDAQ:ZLAB) reported quarterly losses of $(0.80) per share. This is a 18.37 percent increase over losses of $(0.98) per share from the same period last year. The company reported quarterly sales of $109.07 million which beat the analyst consensus estimate of $108.17 million by 0.83 percent. This is a 65.68 percent increase over sales of $65.83 million the same period last year.